FI946077A - Kantasolu- ja lymfosyyttivarastointi - Google Patents

Kantasolu- ja lymfosyyttivarastointi Download PDF

Info

Publication number
FI946077A
FI946077A FI946077A FI946077A FI946077A FI 946077 A FI946077 A FI 946077A FI 946077 A FI946077 A FI 946077A FI 946077 A FI946077 A FI 946077A FI 946077 A FI946077 A FI 946077A
Authority
FI
Finland
Prior art keywords
stem cell
human patient
lymphocyte
cells
storage
Prior art date
Application number
FI946077A
Other languages
English (en)
Swedish (sv)
Other versions
FI946077A0 (fi
Inventor
David Scheer
Bernard M Babior
Original Assignee
David Scheer
Bernard M Babior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David Scheer, Bernard M Babior filed Critical David Scheer
Publication of FI946077A0 publication Critical patent/FI946077A0/fi
Publication of FI946077A publication Critical patent/FI946077A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI946077A 1992-06-25 1994-12-23 Kantasolu- ja lymfosyyttivarastointi FI946077A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90385892A 1992-06-25 1992-06-25
PCT/US1993/006095 WO1994000567A1 (en) 1992-06-25 1993-06-25 Stem cell and lymphocyte storage

Publications (2)

Publication Number Publication Date
FI946077A0 FI946077A0 (fi) 1994-12-23
FI946077A true FI946077A (fi) 1995-01-26

Family

ID=25418173

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946077A FI946077A (fi) 1992-06-25 1994-12-23 Kantasolu- ja lymfosyyttivarastointi

Country Status (10)

Country Link
US (1) US5912174A (fi)
EP (2) EP1002538A3 (fi)
JP (1) JPH08500819A (fi)
AT (1) ATE195872T1 (fi)
AU (1) AU668582B2 (fi)
CA (1) CA2139103A1 (fi)
DE (1) DE69329340T2 (fi)
DK (1) DK0647267T3 (fi)
FI (1) FI946077A (fi)
WO (1) WO1994000567A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2314843A (en) * 1993-07-05 1998-01-14 North Gen Hospital Nhs Trust Whole blood comprising a stabilised leucocyte preparation
JP2000508911A (ja) * 1996-04-19 2000-07-18 オシリス セラピューティクス，インコーポレイテッド 間葉幹細胞を用いる骨の再生および増強
US6415201B1 (en) 1998-04-08 2002-07-02 Andre Lefesvre Process and system for management of batches of components of the haematopoietic system for deferred use
WO1999053030A1 (fr) * 1998-04-08 1999-10-21 Lefesvre Andre Procede et systeme de gestion de lots de cellules immuno-competentes en vue d'utilisations differees
WO1999053029A1 (fr) * 1998-04-08 1999-10-21 Lefesvre Andre Procede et systeme de gestion de lots de lymphocytes ou monocytes en vue d'utilisations differees
GB0031065D0 (en) * 2000-12-20 2001-01-31 Univ Cardiff Preservation of cells
WO2005017117A2 (en) 2003-08-14 2005-02-24 Martin Haas Multipotent amniotic fetal stem cells (mafsc) and banking of same
GB0719751D0 (en) * 2007-10-10 2007-11-21 Antoxis Ltd In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
US20120207715A1 (en) * 2011-02-10 2012-08-16 Hadasit Medical Research Services & Development Ltd. Methods and systems for storing and prolonging viability of matrix dependent cells
JP6741597B2 (ja) * 2014-07-08 2020-08-19 ラ ジョンチャンＲＡ， Ｊｅｏｎｇ Ｃｈａｎ 幹細胞の安定性増進用組成物
WO2019174842A1 (en) 2018-03-13 2019-09-19 Oxacell Ag Cell products with improved stability and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639373A (en) * 1984-11-29 1987-01-27 New England Medical Center Hospitals, Inc. Stabilization of granulocytes
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
FR2600671B1 (fr) * 1986-06-27 1991-01-25 Merieux Inst Procede de conservation cryogenique de substances et matieres organiques, notamment de cellules
US4923797A (en) * 1988-11-29 1990-05-08 President & Fellows Of Harvard College Stabilization of leukocytes

Also Published As

Publication number Publication date
JPH08500819A (ja) 1996-01-30
EP0647267A4 (en) 1996-04-10
DE69329340D1 (de) 2000-10-05
DE69329340T2 (de) 2001-02-01
ATE195872T1 (de) 2000-09-15
FI946077A0 (fi) 1994-12-23
EP0647267B1 (en) 2000-08-30
WO1994000567A1 (en) 1994-01-06
US5912174A (en) 1999-06-15
EP1002538A3 (en) 2000-07-19
CA2139103A1 (en) 1994-01-06
EP0647267A1 (en) 1995-04-12
DK0647267T3 (da) 2000-12-18
AU4651993A (en) 1994-01-24
EP1002538A2 (en) 2000-05-24
AU668582B2 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
NZ334635A (en) Treatment of autoimmune diseases such as rheumatoid arthritis with a vaccine
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
FI946077A (fi) Kantasolu- ja lymfosyyttivarastointi
ATE126055T1 (de) Naproxen-formulierung zur kontrollierten absorption zur einmal täglichen anwendung.
ES290656Y (es) Dispositivo para recoger y mantener vivos los cultivos del cuerpo del paciente.
MX9203543A (es) Medicamento.
DE69229944D1 (de) Verwendung von N-Acylaminoalkoholen zur Herstellung eines Arzneimittels zur Behandlung von Mastzellerkrankungen
HU910979D0 (en) Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
FI930885A (fi) Nervimplantsystem
NO20025179L (no) Produkter for autoimmune sykdommer
ES8608490A1 (es) Procedimiento de obtencion de una preparacion farmaceutica en forma de liberacion lenta y que comprende pinacidil (n'-ciano-n-4-piridil-n'-1, 2, 2-trimetil-propilguanidina), opcionalmente junto con otros componentes
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO162557C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
NO881554L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-((1,1-difenyl)-1-alkenyl)piperazin-derivater og farmasoeytisk aksepterbare salter av disse derivater.
GB9617611D0 (en) Treatment of autoimmune disease
NO164099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.
IT1229511B (it) Dispositivo per la cura chirurgica dell'astigmatismo
AU1370188A (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance
IT8520691V0 (it) Dispositivo per il posizionamento angolare ottimale e la stabilizza zione dello schienale e del sedile d'una sedia in genere